Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

1.

Stromal expression of actin is a marker of aggressiveness in basal cell carcinoma.

Adegboyega PA, Rodriguez S, McLarty J.

Hum Pathol. 2010 Aug;41(8):1128-37. doi: 10.1016/j.humpath.2009.12.014. Epub 2010 Apr 8.

PMID:
20381122
[PubMed - indexed for MEDLINE]
2.

Bcl-2-related proteins, alpha-smooth muscle actin and amyloid deposits in aggressive and non-aggressive basal cell carcinomas.

Bozdogan O, Erkek E, Atasoy P, Koçak M, Birol A, Caydere M.

Acta Derm Venereol. 2002;82(6):423-7.

PMID:
12575847
[PubMed - indexed for MEDLINE]
3.

Actin expression in purely nodular versus nodular-infiltrative basal cell carcinoma.

Law AM, Oliveri CV, Pacheco-Quinto X, Horenstein MG.

J Cutan Pathol. 2003 Apr;30(4):232-6.

PMID:
12680952
[PubMed - indexed for MEDLINE]
4.

Immunoreactivity for alpha-smooth muscle actin characterizes a potentially aggressive subgroup of little basal cell carcinomas.

Pilloni L, Bianco P, Manieli C, Senes G, Coni P, Atzori L, Aste N, Faa G.

Eur J Histochem. 2009 Apr-Jun;53(2):113-6.

PMID:
19683985
[PubMed - indexed for MEDLINE]
5.

A correlation of alpha-smooth muscle actin and invasion in micronodular basal cell carcinoma.

Christian MM, Moy RL, Wagner RF, Yen-Moore A.

Dermatol Surg. 2001 May;27(5):441-5.

PMID:
11359490
[PubMed - indexed for MEDLINE]
6.

Metastatic basal cell carcinoma exhibits reduced actin expression.

Uzquiano MC, Prieto VG, Nash JW, Ivan DS, Gong Y, Lazar AJ, Diwan AH.

Mod Pathol. 2008 May;21(5):540-3. doi: 10.1038/modpathol.3801051. Epub 2008 Jan 25.

PMID:
18223552
[PubMed - indexed for MEDLINE]
Free Article
7.

Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis.

Smith KJ, Williams J, Corbett D, Skelton H.

Am J Surg Pathol. 2001 Apr;25(4):464-71.

PMID:
11257620
[PubMed - indexed for MEDLINE]
8.

Basal cell carcinoma with tumor epithelial and stromal giant cells: a variant of pleomorphic basal cell carcinoma.

Meehan SA, Egbert BM, Rouse RV.

Am J Dermatopathol. 1999 Oct;21(5):473-8. Review.

PMID:
10535579
[PubMed - indexed for MEDLINE]
9.
10.

Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.

Undén AB, Sandstedt B, Bruce K, Hedblad M, Stahle-Bäckdahl M.

J Invest Dermatol. 1996 Aug;107(2):147-53.

PMID:
8757754
[PubMed - indexed for MEDLINE]
11.

bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas.

Ramdial PK, Madaree A, Reddy R, Chetty R.

J Cutan Pathol. 2000 Jul;27(6):283-91.

PMID:
10885404
[PubMed - indexed for MEDLINE]
12.

Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.

Zagrodnik B, Kempf W, Seifert B, Müller B, Burg G, Urosevic M, Dummer R.

Cancer. 2003 Dec 15;98(12):2708-14.

PMID:
14669293
[PubMed - indexed for MEDLINE]
Free Article
13.

Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.

Córdoba A, Guerrero D, Larrinaga B, Iglesias ME, Arrechea MA, Yanguas JI.

Int J Dermatol. 2009 Jul;48(7):713-7. doi: 10.1111/j.1365-4632.2009.04076.x.

PMID:
19570076
[PubMed - indexed for MEDLINE]
14.

P53 and hMSH2 expression in basal cell carcinomas and malignant melanomas from photoexposed areas of head and neck region.

Staibano S, Lo Muzio L, Pannone G, Somma P, Farronato G, Franco R, Bambini F, Serpico R, De Rosa G.

Int J Oncol. 2001 Sep;19(3):551-9.

PMID:
11494035
[PubMed - indexed for MEDLINE]
15.

Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.

Prasad ML, Barbacioru CC, Rawal YB, Husein O, Wen P.

Mod Pathol. 2008 Feb;21(2):105-14. Epub 2007 Dec 14.

PMID:
18084258
[PubMed - indexed for MEDLINE]
Free Article
16.

Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.

Can B, Sökmensüer C.

Hepatogastroenterology. 2003 Dec;50 Suppl 2:ccxliii-ccxlviii.

PMID:
15244191
[PubMed - indexed for MEDLINE]
17.

ILK expression in human basal cell carcinoma correlates with epithelial-mesenchymal transition markers and tumour invasion.

Papanikolaou S, Bravou V, Gyftopoulos K, Nakas D, Repanti M, Papadaki H.

Histopathology. 2010 May;56(6):799-809. doi: 10.1111/j.1365-2559.2010.03556.x.

PMID:
20546345
[PubMed - indexed for MEDLINE]
18.

An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.

Puizina-Ivić N, Sapunar D, Marasović D, Mirić L.

Coll Antropol. 2008 Oct;32 Suppl 2:61-5.

PMID:
19138009
[PubMed - indexed for MEDLINE]
19.

Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinoma.

Bayer-Garner IB, Dilday B, Sanderson RD, Smoller BR.

Am J Dermatopathol. 2000 Apr;22(2):119-22.

PMID:
10770430
[PubMed - indexed for MEDLINE]
20.

Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens.

Ma CK, De Peralta MN, Amin MB, Linden MD, Dekovich AA, Kubus JJ, Zarbo RJ.

Am J Clin Pathol. 1997 Dec;108(6):641-51.

PMID:
9384445
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk